164 related articles for article (PubMed ID: 31669059)
1. Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients.
Kim Y; Wojciechowski D; Pattanayak V; Lee H; Asgari MM
J Invest Dermatol; 2020 May; 140(5):995-1002. PubMed ID: 31669059
[TBL] [Abstract][Full Text] [Related]
2. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
[TBL] [Abstract][Full Text] [Related]
3. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
4. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
5. Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
de Carvalho AV; Bonamigo RR; da Silva CM; Pinto AC
Int J Dermatol; 2012 Dec; 51(12):1448-53. PubMed ID: 23171011
[TBL] [Abstract][Full Text] [Related]
6. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of keratinocyte carcinomas after organ transplantation.
Madeleine MM; Patel NS; Plasmeijer EI; Engels EA; Bouwes Bavinck JN; Toland AE; Green AC;
Br J Dermatol; 2017 Nov; 177(5):1208-1216. PubMed ID: 28994104
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
9. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
10. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
[TBL] [Abstract][Full Text] [Related]
11. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada.
Park CK; Fung K; Austin PC; Kim SJ; Singer LG; Baxter NN; Rochon PA; Chan AW
JAMA Dermatol; 2019 Sep; 155(9):1041-1048. PubMed ID: 31116351
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
Liyanage UE; Law MH; Han X; An J; Ong JS; Gharahkhani P; Gordon S; Neale RE; Olsen CM; ; MacGregor S; Whiteman DC
Hum Mol Genet; 2019 Sep; 28(18):3148-3160. PubMed ID: 31174203
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
Wisgerhof HC; van der Boog PJ; de Fijter JW; Wolterbeek R; Haasnoot GW; Claas FH; Willemze R; Bouwes Bavinck JN
J Invest Dermatol; 2009 Dec; 129(12):2886-94. PubMed ID: 19571820
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary cancer associated with pre-diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma.
Park SM; Li T; Wu S; Li WQ; Qureshi AA; Stampfer M; Cho E
Cancer Epidemiol; 2017 Apr; 47():106-113. PubMed ID: 28242577
[TBL] [Abstract][Full Text] [Related]
17. The association of metformin use with keratinocyte carcinoma development in high-risk patients.
Misitzis A; Stratigos AJ; Beatson M; Mastorakos G; Dellavalle RP; Weinstock MA;
Dermatol Ther; 2020 Nov; 33(6):e14402. PubMed ID: 33047438
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.
Small J; Barton V; Peterson B; Alberg AJ
Adv Cancer Res; 2016; 130():257-91. PubMed ID: 27037755
[TBL] [Abstract][Full Text] [Related]
20. Personal history of keratinocyte carcinoma is associated with reduced risk of death from invasive melanoma in men.
Song F; Chen ST; Li X; Han J
J Am Acad Dermatol; 2018 May; 78(5):957-963. PubMed ID: 29317282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]